Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites

Genes and Development

Volumn 11, Issue 1, 1997, Pages 44-58

  Hurlin, Peter J ^a   Quéva, Christophe ^a   Eisenman, Robert N ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Max; Mnt; mSin3; Myc; repression; transformation; transgenic mouse

Indexed keywords

BINDING PROTEIN; HELIX LOOP HELIX PROTEIN; LEUCINE ZIPPER PROTEIN; RAS PROTEIN; REPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; FIBROBLAST; GENE REPRESSION; HUMAN; HUMAN CELL; KIDNEY CELL; MOUSE; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; RAT;

EID: 0031027008     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.1.44     Document Type: Article

References (74)

1. Amati, B. and H. Land. 1994. Myc-Max-Mad: A transcription factor network controlling cell cycle progression, differentiation and death. Current Opin. Genet. Dev. 4: 102-108.
2. Amati, B., S. Dalton, M.W. Brooks, T.D. Littlewood, G.I. Evan, and H. Land. 1992. Transcriptional activation by the human c-Myc protein in yeast requires interaction with Max. Nature 359: 423-426.
3. Amati, B., M. W. Brooks, N. Levy, T.D. Littlewood, G.I. Evan, and H. Land. 1993a. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell 72: 233-245.
4. Amati, B., T.D. Littlewood, G.I. Evan, and H. Land. 1993b. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J. 12: 5083-5087.
5. Amin, C., A.J. Wagner, and N. Hay. 1993. Sequence-specific transcriptional activation by Myc and repression by Max. Mol. Cell. Biol. 13: 383-390.
6. Armelin, H.A., M.C.S. Armelin, K. Kelly, T. Stewart, P. Leder, B.H. Cochran, and C.D. Stiles. 1984. Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature 310: 655-660.
7. Askew, D.S., R.A. Ashmun, B.C. Simmons, and J.L. Cleveland. 1991. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.Oncogene 6: 1915-1922.
8. Ayer, D.E. and R.N. Eisenman. 1993. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes & Dev. 7: 2110-2119.
9. Ayer, D.E., L. Kretzner, and R.N. Eisenman. 1993. Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72: 211-222.
10. Ayer, D.E., Q.A. Lawrence, and R.N. Eisenman. 1995. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of the yeast repressor Sin3. Cell 80: 767-776.
11. Ayer, D.E., C.D. Laherty, Q.A. Lawrence, A.P. Armstrong, and R.N. Eisenman. 1996. Mad proteins contain a dominant transcription repression domain. Mol. Cell. Biol. 16: 5772-5781.
12. Bello-Fernandez, C., G. Packham, and J.L. Cleveland. 1993. The ornithine decarboxylase gene is a transcriptional target of c-myc. Proc. Natl. Acad. Sci. 90: 7804-7808.
13. Berberich, S., N. Hyde-DeRuyscher, P. Espenshade, and M. Cole. 1992. Max encodes a sequence-specific DNA binding protein and is not regulated by serum growth factors. Oncogene 7: 775-779.
14. Blackwell, T.K., L. Kretzner, E.M. Blackwood, R.N. Eisenman, and H. Weintraub. 1990. Sequence-specific DNA-binding by the c-Myc protein. Science 250: 1149-1151.
15. Blackwood, E.M. and R.N. Eisenman. 1991. Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251: 1211-1217.
16. Blackwood, E.M., L. Kretzner, and R.N. Eisenman. 1992a. Myc and Max function as a nucleoprotein complex. Curr. Opin. Genet. Dev. 2: 227-235.
17. Blackwood, E.M., B. Lüscher, and R.N. Eisenman. 1992b. Myc and Max associate in vivo. Genes &. Dev. 6: 71-80.
18. Campisi, J., H.E. Gray, A.B. Pardee, M. Dean, and G. Sonenshein. 1984. Cell cycle control of c-myc but not c-rasis lost following chemical transformation. Cell 36: 241-247.
19. Charron, J., B.A. Malynn, P. Fisher, V. Stewart, L. Jeanotte, S.P. Goff, E.J. Robertson, and F.W. Alt. 1992. Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes & Dev. 6: 2248-2257.
20. Chen, J.T., L.R. Willinghan, R.L. Margraf, N. Schrieber-Agus, R.A. DePinho, and P.D. Nisen. 1995. Effects of the MYC oncogene antagonist, MAD, on proliferation, cell cycling and the malignant phenotype. Nature Med. 1: 638-643.
21. Coppola, J.A. and M.D. Cole. 1986. Constitutive c-myc expression blocks mouse erythroleukemia cell differentiation but not commitment. Nature 320: 760-763.
22. Cory, S. and J. Adams. 1988. Transgenic mice and oncogenesis. Annu. Rev. Immunol. 6: 25-48.
23. Crouch, D.H., F. Fisher, W. Clark, P. Jayaraman, C.R. Goding, and D.A.F. Gillespie. 1993. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity. Oncogene 8: 1849-1855.
24. Davis, A.C., M. Wims, G.D. Spotts, S.R. Hann, and A. Bradley. 1993. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygous and reduced fertility in heterozygous female mice. Genes & Dev. 7: 671-682.
25. DePinho, R.A., N. Schreiber-Agus, and F.W. Alt. 1991. myc family oncogenes in the development of normal and neoplastic cells. Adv. Cancer Res. 57: 1-46.
26. Desharats, L., S. Gaubatz, and M. Eilers. 1996. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. Genes & Dev. 10: 447-460.
27. Downs, K.M., G.R. Martin, and J.M. Bishop. 1989. Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo. Genes &. Dev. 3: 860-869.
28. Evan, G.I., A.H. Wyllie, C.S. Gilbert, T.D. Littlewood, H. Land, M. Brooks, C.M. Waters, L.Z. Penn, and D.C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 1-20.
29. Ferré-D'Amaré, A.R., G.G. Prendergast, E.B. Ziff, and S.K. Burley. 1993. Recognition of Max by its cognate DNA through a dimeric b/HLH/Z domain. Nature 363: 38-46.
30. Galaktionov, K., X. Chen, and D. Beach. 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382: 511-517.
31. Gaubatz, S., A. Imhof, R. Dosch, O. Werner, P. Mitchell, R. Buettner, and M. Eilers. 1995. Transcription activation by Myc is under negative control by the transcription factor AP-2. EMBO J. 14: 1508-1519.
32. Grandori, C., J. Mac, F. Siebelt, D.E. Ayer, and R.N. Eisenman. 1996. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J. 15: 4344-4357.
33. Gu, W., K. Cechova, V. Tassi, and R. Dalla-Favera. 1993. Opposite regulation of gene transcription by c-Myc and Max. Proc. Natl. Acad. Sci. 90: 2935-2939.
34. Hann, S.R. and R.N. Eisenman. 1984. Protein encoded by the human c-myc oncogene: Differential expression in neoplastic cells. Mol Cell. Biol. 4: 2486-2497.
35. Harper, S.E., Y. Qiu, and P.A. Sharp. 1996. Sin3 corepressor function in Myc-induced transcription and transformation. Proc. Natl. Acad. Sci 93: 8536-8540.
36. Henikoff, S. 1994. Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing. Gene 28: 351-359.
37. Henriksson, M. and B. Luscher. 1996. Proteins of the Myc network: Essential regulators of cell growth and differentiation. Adv. Cancer Res. 68: 109-182.
38. Hogan, B., R. Beddington, F. Constantini, and E. Lacy. 1994. Manipulating the mouse embryo. Cold Spring Harbor Labortory Press, Cold Spring Harbor, NY.
39. Hollenberg, S.M., R. Sternglanz, P.F. Cheng, and H. Weintraub. 1995. Identification of a new family of tissue-specific helix-loop-helix proteins with a two-hybrid system. Mol. Cell. Biol. 15: 3813-3822.
40. Hurlin, P.J., D.A. Ayer, C. Grandori, and R.E. Eisenman. 1994. The Max transcription network: Involvement of Mad in differentiation and an approach to identification of target genes. Cold Spring Harbor Symp. Quant. Biol 59: 109-116.
41. Hurlin, P.J., K.P. Foley, D.E. Ayer, R.N. Eisenman, D. Hanahan, and J.M. Arbeit. 1995a. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. Oncogene 11: 2487-2501.
42. Hurlin, P.J., C. Quéva, P.J. Koskinen, E. Steingrimsson, D.E. Ayer, N.G. Copeland, N.A. Jenkins, and R.N. Eisenman. 1995b. Mad3 and Mad4: Novel Max-interacting transcriptional repressors that suppress c-Myc-dependent transformation and are expressed during neural and epidermal differentiation. EMBO J. 14: 5646-5659.
43. Johnson, A.D. 1995. The price of repression. Cell 81: 655-658. Kastan, M.M., D.E. Ayer, and D.J. Stillman. 1996. SIN3-dependent transcriptional repression by interaction with the Mad1 DNA-binding protein. Mol. Cell. Biol. 16: 4215-4221.
44. Johnson, A.D. 1995. The price of repression. Cell 81: 655-658. Kastan, M.M., D.E. Ayer, and D.J. Stillman. 1996. SIN3-dependent transcriptional repression by interaction with the Mad1 DNA-binding protein. Mol. Cell. Biol. 16: 4215-4221.
45. Kato, G., J. Barrett, J.M. Villa-Garcia, and C.V. Dang. 1990. An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol. 10: 5914-5920.
46. Kelly, K., B.H. Cochran, C.D. Stiles, and P. Leder. 1983. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35: 603-610.
47. Koskinen, P.J., D.G. Ayer, and R.E. Eisenman. 1995. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions. Cell Growth Differ. 6: 623-629.
48. Kretzner, L., E.M. Blackwood, and R.N. Eisenman. 1992. The Myc and Max proteins possess distinct transcriptional activities. Nature 359: 426-429.
49. Lahoz, E.G., L. Xu, N. Schreiber-Agus, and R.A. DePinho. 1994. Suppression of Myc, but not E1a transformation activity by Max-associated proteins, Mad and Mxil. Proc. Natl. Acad. Sci. 91: 5503-5507.
50. Land, H., L.F. Parada, and R.A. Weinberg. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304: 596-601.
51. Li, L.H., D. MacGregor, C. Nerlov, G. Prendergast, and E.B. Ziff. 1994. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J. 13: 4070-4079.
52. Litofsky, N.S., D. Hinton, and C. Raffel. 1994. The lack of a role for p53 in astrocytomas in pediatric patients. Neurosurgery 34: 967-972.
53. Littlewood, T.D., B. Amati, H. Land, and G.I. Evan. 1992. Max and C-Myc/Max DNA-binding activities in cell extracts. Oncogene 7: 1783-1792.
54. Lüscher, B. and R.E. Eisenman. 1990. New light on Myc and Myb. Part I. Myc. Genes & Dev. 4: 2025-2035.
55. Mäkelä, T.P., P.J. Koskinen, I. Västrik, and K. Alitalo. 1992. Alternative forms of Max as enhancers or suppressors of Myc-Ras cotransformation. Science 256: 373-377.
56. Marcu, K.B., S.A. Bossone, and A.J. Patel. 1992. myc function and regulation. Annu. Rev, Biochem. 61: 809-860.
57. Moens, C.B., A.B. Auerbach, R.A. Conlon, A.L. Joyner, and J. Rossant. 1992. A targeted mutation reveals a role for N-myc in branching morphogenesis in the embryonic mouse lung. Genes & Dev. 6: 691-704.
58. Moens, C.B., B.R. Stanton, L.F. Parada, and J. Rossant. 1993. Defects in heart and lung development in compound heterozygotes for two different targeted mutations at the N-myc locus. Development 119: 485-499.
59. Mukherjee, B., S.D. Morgenbesser, and R.A. DePinho. 1992. Myc family oncoproteins function through a common pathway to transform cells in culture: Cross-inteference by Max and trans-acting dominant mutants. Genes &. Dev. 7: 2110-2119.
60. Packham, G. and J.L. Cleveland. 1994. Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol. Cell. Biol. 14: 5741-5747.
61. Phillips, N.J., M.R. Ziegler, D.M. Radford, K.L. Fair, T. Steinbrueck, F.P. Xynos, and H. Donis-Keller. 1996. Allelic deletion on chromosome 17p13.3 in early ovarian cancer. Cancer Res. 56: 606-611.
62. Prendergast, G.C., D. Lawe, and E.B. Ziff. 1991. Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and Ras cotransformation. Cell 65: 395-407.
63. Roussel, M.F., R.A. Ashmun, C.J. Sherr, R.N. Eisenman, and D.E. Ayer. 1996. Inhibition of cell proliferation by the Mad1 transcriptional repressor. Mol. Cell. Biol. 16: 2796-2801.
64. Roy, A.L., T. Gutjahr, C. Carruthers, and R.G. Roeder. 1993. Direct role for Myc in transcription initiation mediated by interactions with TFII-I. Nature 365: 359-361.
65. Sawai, S., A. Shimono, Y. Wakamatsu, C. Palmes, K. Hanaoka, and H. Kondoh. 1993. Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. Development 117: 1445-1455.
66. Schmid, P., W.A. Schultz, and H. Hameister. 1989. Dynamic expression of the myc proto-oncogene in mid-gestation mouse embryos. Science 243: 226-229.
67. Schreiber-Agus, N., L. Chin, K. Chen, R. Torres, G. Rao, P. Guida, A.I. Skoultchi, and R. DePinho. 1995. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 80: 777-786.
68. Spencer, C.A. and M. Groudine. 1991. Control of c-Myc regulation in normal and neoplastic cells. Adv. Cancer Res. 56: 1-48.
69. Stanton, B.R., A.S. Perkins, L. Tessarollo, D.A. Sassoon, and L.F. Parada. 1992. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo. Genes & Dev. 6: 2235-2247.
70. Västrik, I., A. Kaipainern, T.-L. Penttila, A. Lymboussakis, R. Alitai, M. Parvinen, and K. Alitalo. 1995. Expression of the mad gene during cell differentiation in vivo and its inhibition of cell growth in vitro. J. Cell Biol. 128: 1197-1208.
71. Vojtek, A.B., S.M. Hollenberg, and J.A. Cooper. 1993. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74: 205-214.
72. Wagner, A.J., C. Meyers, L.A. Laimins, and N. Hay. 1993. c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ. 4: 879-883.
73. Wilkie, T.M., R.L. Brinster, and R.D. Palmiter. 1986. Germline and somatic mosaicism in transgenic mice. Dev. Biol. 118: 9-18.
74. Zervos, A.S., J. Gyuris, and R. Brent. 1993. Mxil, a protein that specifically interacts with Max to hind Myc-Max recognition sites. Cell 72: 223-232.